Abstract

Using

Author(s): Rasha Awaw

The field of lung disease research has long relied on traditional animal models and in vitro systems to investigate human pulmonary pathophysiology. However, these models often fail to capture the complexity of human lung function and disease. Recent advancements in microfluidic technology have led to the development of the “lung-on-a-chip” model, a novel in vitro system that mimics the physiological environment of human lungs. This opinion article explores the potential of lung-on-a-chip technology to revolutionize the study of human breathing, offering new insights into lung disease mechanisms, drug testing, and therapeutic development.